Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Assets Average: 2009-2022

Historic Assets Average for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Sep 2022 value amounting to $151.8 million.

  • Avadel Pharmaceuticals' Assets Average fell 44.45% to $151.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $151.8 million, marking a year-over-year decrease of 44.45%. This contributed to the annual value of $279.5 million for FY2021, which is 20.69% up from last year.
  • Avadel Pharmaceuticals' Assets Average amounted to $151.8 million in Q3 2022, which was down 19.88% from $189.5 million recorded in Q2 2022.
  • Over the past 5 years, Avadel Pharmaceuticals' Assets Average peaked at $334.5 million during Q3 2020, and registered a low of $151.8 million during Q3 2022.
  • In the last 3 years, Avadel Pharmaceuticals' Assets Average had a median value of $273.3 million in 2021 and averaged $254.8 million.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Assets Average plummeted by 47.56% in 2019 and then spiked by 108.04% in 2020.
  • Quarterly analysis of 5 years shows Avadel Pharmaceuticals' Assets Average stood at $229.7 million in 2018, then plummeted by 33.09% to $153.7 million in 2019, then soared by 108.01% to $319.6 million in 2020, then declined by 20.01% to $255.7 million in 2021, then plummeted by 44.45% to $151.8 million in 2022.
  • Its last three reported values are $151.8 million in Q3 2022, $189.5 million for Q2 2022, and $234.2 million during Q1 2022.